Smith & Nephew has built a fully active portfolio where family structures run deep relative to the overall portfolio size, reflecting a strategy of filing related patents around a focused set of core inventions. Their IP spans the full range of technology domains in robotic surgery. On the commercial side, regulatory output and acquisition activity are the two defining signals, with both contributing meaningfully to their business profile.
What is GreyB Spotlight?
GreyB Spotlight recognizes the top 1% innovators. Patent intelligence trusted by 70% of the Fortune 500. We evaluate Emerging Innovator status and Portfolio Strength. Awards are issued only after research surfaces qualifying signals. No applications. No quotas. No nominations.
